Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

BACKGROUND The predominant strain during the 2013-2014 influenza season was 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09). This vaccine-component has remained unchanged from 2009. METHODS The US Flu Vaccine Effectiveness Network enrolled subjects aged ≥6 months with medically attended acute respiratory illness (MAARI), including cough, with illness onset ≤7 days before enrollment. Influenza was confirmed by reverse-transcription polymerase chain reaction (RT-PCR). We determined the effectiveness of trivalent or quadrivalent inactivated influenza vaccine (IIV) among subjects ages ≥6 months and the effectiveness of quadrivalent live attenuated influenza vaccine (LAIV4) among children aged 2-17 years, using a test-negative design. The effect of prior receipt of any A(H1N1)pdm09-containing vaccine since 2009 on the effectiveness of current-season vaccine was assessed. RESULTS We enrolled 5999 subjects; 5637 (94%) were analyzed; 18% had RT-PCR-confirmed A(H1N1)pdm09-related MAARI. Overall, the effectiveness of vaccine against A(H1N1)pdm09-related MAARI was 54% (95% confidence interval [CI], 46%-61%). Among fully vaccinated children aged 2-17 years, the effectiveness of LAIV4 was 17% (95% CI, -39% to 51%) and the effectiveness of IIV was 60% (95% CI, 36%-74%). Subjects aged ≥9 years showed significant residual protection of any prior A(H1N1)pdm09-containing vaccine dose(s) received since 2009, as did children <9 years old considered fully vaccinated by prior season. CONCLUSIONS During 2013-2014, IIV was significantly effective against A(H1N1)pdm09. Lack of LAIV4 effectiveness in children highlights the importance of continued annual monitoring of effectiveness of influenza vaccines in the United States.

[1]  Erin Burns,et al.  Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine. , 2016, MMWR. Morbidity and mortality weekly report.

[2]  T. R. Peters,et al.  Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States. , 2016, Vaccine.

[3]  M. Loeb,et al.  Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination. , 2015, Vaccine.

[4]  L. Grohskopf,et al.  Prevention and Control of Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  D. Skowronski,et al.  Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.

[6]  Kenneth J Rothman,et al.  Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. , 2015, Vaccine.

[7]  A. Antón,et al.  Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons , 2015, Human vaccines & immunotherapeutics.

[8]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[9]  G. Dowse,et al.  Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. , 2014, Vaccine.

[10]  T. Friedrich,et al.  Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Yang,et al.  Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. , 2014, Vaccine.

[12]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season , 2014, Morbidity and Mortality Weekly Report.

[13]  K. Subbarao,et al.  The Matrix Gene Segment Destabilizes the Acid and Thermal Stability of the Hemagglutinin of Pandemic Live Attenuated Influenza Virus Vaccines , 2014, Journal of Virology.

[14]  G. Aldrovandi,et al.  School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  C Moore,et al.  Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  D. Skowronski,et al.  Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.

[17]  Lynnette Brammer,et al.  Influenza Activity — United States, 2013–14 Season and Composition of the 2014–15 Influenza Vaccines , 2014, MMWR. Morbidity and mortality weekly report.

[18]  Jose L. Sanchez,et al.  Brief report: mid-season influenza vaccine effectiveness estimates for the 2013-2014 influenza season. , 2014, MSMR.

[19]  D. Skowronski,et al.  Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.

[20]  U. Buchholz,et al.  Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  A. Monto,et al.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  H. Jin,et al.  A Single Amino Acid in the Stalk Region of the H1N1pdm Influenza Virus HA Protein Affects Viral Fusion, Stability and Infectivity , 2014, PLoS pathogens.

[23]  K. Hancock,et al.  Antibody Response to Influenza A(H1N1)pdm09 Among Healthcare Personnel Receiving Trivalent Inactivated Vaccine: Effect of Prior Monovalent Inactivated Vaccine , 2013, The Journal of infectious diseases.

[24]  L. Grohskopf,et al.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[25]  Michael Haber,et al.  The case test-negative design for studies of the effectiveness of influenza vaccine. , 2013, Vaccine.

[26]  A. Monto,et al.  Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine. , 2012, The Journal of infectious diseases.

[27]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  J. Falloon,et al.  Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children , 2012, The Pediatric infectious disease journal.

[29]  W Carman,et al.  Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom , 2012, Epidemiology and Infection.

[30]  D. Skowronski,et al.  A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J. Falloon,et al.  randomized , double-blind noninferiority study of quadrivalent live attenuated nfluenza vaccine in adults , 2011 .

[32]  M. Valenciano,et al.  I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe , 2011, PloS one.

[33]  A. Monto,et al.  Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities , 2011, PloS one.

[34]  N. Andrews,et al.  Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England , 2011, The Journal of infectious diseases.

[35]  E. Belongia,et al.  Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. , 2009, Vaccine.

[36]  W. Gruber,et al.  Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children , 2008, Clinical and Vaccine Immunology.

[37]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[38]  U. Wahn,et al.  Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma , 2006, The Pediatric infectious disease journal.

[39]  W. Gruber,et al.  Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections , 2006, The Pediatric infectious disease journal.

[40]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[41]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[42]  A. Monto,et al.  Interim estimates of 2013-14 seasonal influenza vaccine effectiveness - United States, February 2014. , 2014, MMWR. Morbidity and mortality weekly report.

[43]  Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine. , 2012, MMWR. Morbidity and mortality weekly report.

[44]  Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine. , 2011, MMWR. Morbidity and mortality weekly report.

[45]  Update: influenza activity - United States, 2009-10 season. , 2010, MMWR. Morbidity and mortality weekly report.

[46]  G. Beeson,et al.  in adults with , 2019 .